FR2041M - Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions. - Google Patents

Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.

Info

Publication number
FR2041M
FR2041M FR894712A FR894712A FR2041M FR 2041 M FR2041 M FR 2041M FR 894712 A FR894712 A FR 894712A FR 894712 A FR894712 A FR 894712A FR 2041 M FR2041 M FR 2041M
Authority
FR
France
Prior art keywords
ascorbic acid
metal ions
therapeutic composition
properties based
cytotoxic properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR894712A
Other languages
French (fr)
Inventor
Andre Anselme Marie Luc Cier
Louis Eugene Marie Colobert
Claude Andre Joseph Nofre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANDRE ANSELME MARIE LUC CIER
CLAUDE ANDRE JOSEPH NOFRE
LOUIS EUGENE MARIE COLOBERT
ANDRE ANSELME MARIE
Original Assignee
ANDRE ANSELME MARIE LUC CIER
CLAUDE ANDRE JOSEPH NOFRE
LOUIS EUGENE MARIE COLOBERT
ANDRE ANSELME MARIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL287675D priority Critical patent/NL287675A/xx
Priority to BE626516D priority patent/BE626516A/xx
Priority to FR884715A priority patent/FR1320776A/en
Application filed by ANDRE ANSELME MARIE LUC CIER, CLAUDE ANDRE JOSEPH NOFRE, LOUIS EUGENE MARIE COLOBERT, ANDRE ANSELME MARIE filed Critical ANDRE ANSELME MARIE LUC CIER
Priority to FR894712A priority patent/FR2041M/en
Priority to ES283891A priority patent/ES283891A1/en
Priority to US250790A priority patent/US3329607A/en
Priority to GB1597/63A priority patent/GB1034433A/en
Application granted granted Critical
Publication of FR2041M publication Critical patent/FR2041M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
FR894712A 1962-01-12 1962-04-17 Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions. Active FR2041M (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL287675D NL287675A (en) 1962-01-12
BE626516D BE626516A (en) 1962-01-12
FR884715A FR1320776A (en) 1962-01-12 1962-01-12 Process and chemical composition for biological purification of feed water
FR894712A FR2041M (en) 1962-04-17 1962-04-17 Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.
ES283891A ES283891A1 (en) 1962-01-12 1963-01-03 Procedure for the obtaining of compounds of bactericidal, virulicidal, antiparasitary and cytotoxic properties (Machine-translation by Google Translate, not legally binding)
US250790A US3329607A (en) 1962-01-12 1963-01-11 Method for the biological purification of drinking water
GB1597/63A GB1034433A (en) 1962-01-12 1963-01-14 Bactericidal, viricidal, anti-parasitic and cytotoxic compositions and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR894712A FR2041M (en) 1962-04-17 1962-04-17 Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.

Publications (1)

Publication Number Publication Date
FR2041M true FR2041M (en) 1963-09-30

Family

ID=87556656

Family Applications (1)

Application Number Title Priority Date Filing Date
FR894712A Active FR2041M (en) 1962-01-12 1962-04-17 Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.

Country Status (1)

Country Link
FR (1) FR2041M (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110467A (en) * 1976-12-13 1978-08-29 Fujisawa Pharmaceutical Co., Ltd. Prophylactic, therapeutic or hygienical agent against virus diseases in fish and use therefor
WO2007080108A1 (en) * 2006-01-10 2007-07-19 Multibind Biotec Gmbh Composition ascorbic acid and a metal ion for selective killing of pathological mammalian cells
WO2009000551A1 (en) * 2007-06-28 2008-12-31 Bode Chemie Gmbh Use of a synergistic composition as a therapeutic agent or disinfectant
EP3042652A4 (en) * 2013-09-05 2017-04-12 Profeat Biotechnology Co. Ltd. Use of composition containing ferrous amino acid chelate in preparation of anti-cancer medicament
US10702494B2 (en) 2013-09-05 2020-07-07 Profeat Biotechnology Co., Ltd. Method for cancer treatment

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110467A (en) * 1976-12-13 1978-08-29 Fujisawa Pharmaceutical Co., Ltd. Prophylactic, therapeutic or hygienical agent against virus diseases in fish and use therefor
WO2007080108A1 (en) * 2006-01-10 2007-07-19 Multibind Biotec Gmbh Composition ascorbic acid and a metal ion for selective killing of pathological mammalian cells
WO2009000551A1 (en) * 2007-06-28 2008-12-31 Bode Chemie Gmbh Use of a synergistic composition as a therapeutic agent or disinfectant
EP2489370A1 (en) * 2007-06-28 2012-08-22 Bode Chemie GmbH Use of a synergistic compound as a therapeutic agent or disinfectant
US8557265B2 (en) 2007-06-28 2013-10-15 Bode Chemie Gmbh Use of a synergistic composition as a therapeutic agent of disinfectant
EP3042652A4 (en) * 2013-09-05 2017-04-12 Profeat Biotechnology Co. Ltd. Use of composition containing ferrous amino acid chelate in preparation of anti-cancer medicament
US10702494B2 (en) 2013-09-05 2020-07-07 Profeat Biotechnology Co., Ltd. Method for cancer treatment

Similar Documents

Publication Publication Date Title
FR3152M (en) N-alkyl- and n-arylalkyl-benzoxacyclo-alkane-carboxamides as analgesics and hypotensive drugs.
FR2041M (en) Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.
FR1356196A (en) Tin oxide resistors
FR3271M (en) N-alkyl- and n-arylalkyl-benzoxacycloalkanemethylamines as analgesics and hypotensive drugs.
FR2354M (en) Composition based on steroids and 2-methyl-3-indolyl-aliphatic acid for the treatment of inflammation.
FR1372266A (en) Articulation bearing
FR1333998A (en) Fertilizer distributor-sprayer
FR3026M (en) Narcotic drug based on 3-methoxy-4-n-ethyloxy-n-ethylcarbaminomethoxyphenylacetic acid n-propyl ester.
FR1330081A (en) New Aliphatic Hydrocarbon Compositions and Their Preparation
BE618968A (en) Therapeutic composition with hypocholesterolemic action based on nicotinic acid N-oxide
FR1344243A (en) Aroma diffuser
FR1312892A (en) New 1.4-benzodioxanes and their preparation
FR1312891A (en) New 1.5-benzo-dioxepannes and their preparation
FR2863M (en) New estradiol esters.
FR1352913A (en) Oxymethylene copolymers their manufacture and applications
FR1342564A (en) 5. 6. 7. 8-tetraethyl-anthraquinone-1-carboxylic acid and its preparation
BE600553A (en) New 1.2-diaryl-3.5-dioxo-pyrazolidines substituted in position 4 and their preparation
FR2841M (en) Coronarodilator drug based on esters of mandelic acid.
FR1319519A (en) 2.5-Diarylamino-terephthalic acids and their preparation
FR1323437A (en) Preparation of substituted phenols, in particular alkylmercapto-phenols
FR2935M (en) N-substituted anthranilic acid alkyl esters and their use in therapy.
FR1808M (en) Combination of acetylsalicylic acid and deltahydrocortisone.
ES93206Y (en) Children's game table
FR2918M (en) Hydroxy-17β oxa-4 δ <1> -5α androstenones-3, in particular those 17-alkylated, and esters derived therefrom.
AU264776B2 (en) The n - oxide of n ( 3' - dimothylominopropyl ) - imidobenzyl its acid addition salts and their manufacture